Old Web
English
Sign In
Acemap
>
authorDetail
>
Frank Striebel
Frank Striebel
MorphoSys
Medicine
Immunology
Neutropenia
Bendamustine
Follicular lymphoma
3
Papers
10
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Tafasitamab combined with idelalisib or venetoclax in patients with CLL previously treated with a BTK inhibitor.
2021
Leukemia & Lymphoma
Philipp B. Staber
Wojciech Jurczak
Richard Greil
Vladan Vucinic
Jan Moritz Middeke
Marco Montillo
Talha Munir
Peter Neumeister
Johannes Schetelig
Stephan Stilgenbauer
Frank Striebel
Maren Dirnberger-Hertweck
Johannes Weirather
Wolfram Brugger
Peter Kelemen
Clemens-Martin Wendtner
Jennifer A. Woyach
Show All
Source
Cite
Save
Citations (0)
Expression of CD19 Antigen on Chronic Lymphocytic Leukemia Cells after Tafasitamab (Anti-CD19) Treatment: Phase I Trial Data
2019
Blood
Rainer Boxhammer
Frank Striebel
Roland Baumgartner
Jan Endell
Show All
Source
Cite
Save
Citations (2)
Phase IIa Study of Single-Agent MOR208 in Patients with Relapsed or Refractory B-Cell Non-Hodgkin9s Lymphoma
2015
Blood
Wojciech Jurczak
Pier Luigi Zinzani
Gianluca Gaidano
Andre Goy
Mariano Provencio
Zsolt Nagy
Tadeusz Robak
Kami J. Maddocks
Christian Buske
Roman Pawel Korolkiewicz
Frank Striebel
Kristie A. Blum
Show All
Source
Cite
Save
Citations (8)
1